Glucagon for Esophageal Obstruction: Technical Pros and Cons
Abstract: Glucagon, a 29-amino acid peptide, is utilized off-label for esophageal food bolus obstruction, leveraging its smooth muscle relaxant properties. Technical pros include non-invasive administration and rapid onset (5-10 minutes), with success rates of 30-50% in distal obstructions. Cons involve limited efficacy for complete blockages, contraindications (e.g., pheochromocytoma, insulinoma), and transient adverse effects (nausea, vomiting). Market trends show rising demand for peptide-based emergency therapeutics, with glucagon’s niche in gastroenterology. Brand comparisons highlight Novo Nordisk’s GlucaGen® versus generic formulations, differing in reconstitution time and stability. Product parameters include 1 mg dosage, pH 2.5-3.5, and 24-hour stability post-reconstitution. Regulatory compliance (FDA, EMA) and cold-chain logistics (2-8°C) are critical. Peptide industry growth (CAGR 8.5%) supports glucagon’s role, though alternatives like endoscopic intervention remain superior for high-risk cases.